Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Other Operating Expenses (2021 - 2025)

PAVmed (PAVM) has 5 years of Other Operating Expenses data on record, last reported at $255000.0 in Q3 2025.

  • For Q3 2025, Other Operating Expenses changed N/A year-over-year to $255000.0; the TTM value through Sep 2025 reached $1.0 million, changed N/A, while the annual FY2024 figure was $17.0 million, 1602.6% up from the prior year.
  • Other Operating Expenses reached $255000.0 in Q3 2025 per PAVM's latest filing, down from $262000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $7.7 million in Q4 2022 and bottomed at -$17.1 million in Q1 2022.
  • Average Other Operating Expenses over 5 years is $1.1 million, with a median of $2.0 million recorded in 2021.
  • Peak YoY movement for Other Operating Expenses: soared 542.7% in 2024, then tumbled 95.64% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $3.9 million in 2021, then skyrocketed by 98.21% to $7.7 million in 2022, then tumbled by 87.08% to $1.0 million in 2023, then tumbled by 79.5% to $205000.0 in 2024, then increased by 24.39% to $255000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Operating Expenses were $255000.0 in Q3 2025, $262000.0 in Q2 2025, and $283000.0 in Q1 2025.